Our ventricular assist device (VAD) and artificial heart program goes hand-in-hand with our leading heart transplant program. UCLA's hospitals also have the capacity to support patients from infancy through adulthood.
Our surgeons and cardiologists are highly experienced in all types of mechanical circulatory support, and many have expertise in transplants as well. Learn more about our ventricular assist devices and artificial heart.
Because of our expertise, clinical researchers and device manufacturers regularly call upon our physicians and other experts to evaluate new technologies.
That means when a new technology is approved, we frequently have experience with it from clinical trials and can make it available to patients very quickly.
We test many of the newest devices before they are approved for general use. As a result, our surgical teams, cardiomyopathy specialists, nurses and VAD coordinators are among the most experienced and knowledgeable anywhere.
Mechanical circulatory support such as ventricular assist devices (VADs) and artificial hearts can prolong the lives of patients with end-stage heart disease in two ways:
Before determining which path to follow, we thoroughly evaluate each patient. This assessment involves:
With a mechanical circulatory support device, it is very important to evaluate the patient's quality of life after the surgery. We provide extensive patient education and preparation for patients who will be living with a VAD/artificial heart.
To learn more about mechanical circulatory support, VAD and artificial heart at UCLA, please contact the Ahmanson-UCLA Cardiomyopathy Center at (310) 825-8816 or (310) 206-6766 (page operator).